Encompass Health (NYSE:EHC) Issues FY 2024 Earnings Guidance

Encompass Health (NYSE:EHC) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 3.970-4.220 for the period, compared to the consensus earnings per share estimate of 4.110. The company issued revenue guidance of $5.3 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion.

Wall Street Analysts Forecast Growth

EHC has been the subject of a number of research analyst reports. Royal Bank of Canada lifted their target price on Encompass Health from $83.00 to $95.00 and gave the stock an outperform rating in a report on Wednesday, May 22nd. SVB Leerink assumed coverage on shares of Encompass Health in a research note on Wednesday, July 10th. They issued an outperform rating and a $100.00 price objective for the company. Truist Financial raised their price target on shares of Encompass Health from $95.00 to $100.00 and gave the stock a buy rating in a report on Monday, July 15th. Mizuho upped their price objective on shares of Encompass Health from $93.00 to $95.00 and gave the company a buy rating in a report on Thursday, April 25th. Finally, Stephens restated an overweight rating and issued a $105.00 target price on shares of Encompass Health in a research note on Tuesday. Eight investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of Buy and an average price target of $99.86.

Encompass Health Stock Down 4.9 %

Shares of NYSE:EHC traded down $4.37 during midday trading on Tuesday, hitting $85.30. 1,248,615 shares of the company’s stock were exchanged, compared to its average volume of 651,251. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.37. Encompass Health has a 12 month low of $57.55 and a 12 month high of $94.38. The company has a market cap of $8.59 billion, a PE ratio of 22.82, a price-to-earnings-growth ratio of 1.45 and a beta of 0.89. The stock has a 50 day moving average price of $86.43 and a 200-day moving average price of $81.24.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Monday, August 5th. The company reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.10. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same period in the previous year, the company posted $0.95 EPS. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. On average, sell-side analysts anticipate that Encompass Health will post 4.09 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be given a dividend of $0.17 per share. This is a positive change from Encompass Health’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date is Tuesday, October 1st. Encompass Health’s dividend payout ratio (DPR) is presently 18.38%.

Insider Buying and Selling

In other Encompass Health news, insider Elissa Joy Charbonneau sold 10,000 shares of the stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $85.02, for a total value of $850,200.00. Following the completion of the sale, the insider now owns 18,594 shares in the company, valued at approximately $1,580,861.88. The transaction was disclosed in a document filed with the SEC, which is available at this link. 2.10% of the stock is owned by corporate insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.